Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1+ TAMsBetül Gök Yavuz, Dicle Güç|Scientific Reports|2019Cited by 286
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trialAhmed O. Kaseb, Padmanee Sharma, Hop Sanderson Tran Cao et al.|The Lancet. Gastroenterology & hepatology|2022Cited by 255